Zobrazeno 1 - 10
of 28
pro vyhledávání: '"A.B.G. Kwast"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
A.B.G. Kwast, Liesbeth Jansen, Gooitzen M. van Dam, Jakob de Vries, Rosanne Lanting, Sabine Siesling, Joost Bart, Rick G. Pleijhuis, Theo Wiggers
Publikováno v:
The Breast, 22(5), 773-779. Churchill Livingstone
BACKGROUND: Breast-conserving therapy, consisting of lumpectomy and adjuvant radiotherapy, is considered standard treatment for early-stage breast cancer. One of the most important risk factors of local recurrence is the presence of positive surgical
Publikováno v:
European Journal of Cancer Care. 22:754-764
Increased breast cancer incidence and better survival have raised the number of patients requiring follow-up care. Despite guidelines, there is controversy about appropriate breast cancer follow-up. Therefore, semi-structured interviews were conducte
Publikováno v:
International Journal of Cancer; Vol 132
International Journal of Cancer
International journal of cancer, 132(12), 2910-2917. Wiley
International Journal of Cancer
International journal of cancer, 132(12), 2910-2917. Wiley
EUROCHIP (European Cancer Health Indicators Project) focuses on understanding inequalities in the cancer burden, care and survival by the indicators "stage at diagnosis," "cancer treatment delay" and "compliance with cancer guidelines" as the most im
Publikováno v:
European journal of oncology nursing, 16(3), 281-285. Elsevier
Purpose: To evaluate adherence with follow-up criteria as suggested by the national guideline for breast cancer patients. Method: Patients diagnosed with breast cancer in 2003 in two hospitals were identified from the Netherlands Cancer Registry (n =
Autor:
Eva Steliarova-Foucher, M. O'Callaghan, Harry Comber, C.J.G. van den Hurk, J.W.W. Coebergh, W.J. Louwman, Roberto Zanetti, Hans H. Storm, A.B.G. Kwast, Stefano Rosso, Sabine Siesling
Publikováno v:
European journal of cancer, 51(9), 1039-1049. Elsevier
European Journal of Cancer, 51(9), 1039-1049. Elsevier Ltd.
Europe PubMed Central
European Journal of Cancer, 51(9), 1039-1049. Elsevier Ltd.
Europe PubMed Central
Aim: To provide insight into cancer registration coverage, data access and use in Europe. This contributes to data and infrastructure harmonisation and will foster a more prominent role of cancer registries (CRs) within public health, clinical policy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4109f5844b9fd1fd8d577f0c45c908ee
https://research.utwente.nl/en/publications/6f7cb7ab-3f50-49e0-b2a2-70b27aaef7c6
https://research.utwente.nl/en/publications/6f7cb7ab-3f50-49e0-b2a2-70b27aaef7c6
Publikováno v:
PLoS ONE
PLoS ONE, 10(4):e0120832. Public Library of Science
PLoS ONE, Vol 10, Iss 4, p e0120832 (2015)
PLoS ONE, 10(4):e0120832. Public Library of Science
PLoS ONE, Vol 10, Iss 4, p e0120832 (2015)
The association between the disease-free interval (DFI) and survival after a locoregional recurrence (LRR) or second primary (SP) breast cancer remains uncertain. The objective of this study is to clarify this association to obtain more information o
Autor:
Sabine Siesling, A.B.G. Kwast, Rick G. Pleijhuis, Gooitzen M. van Dam, Liesbeth Jansen, Jakob de Vries, Theo Wiggers
Publikováno v:
The Breast, 24(5), 540-542. Churchill Livingstone
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cc6e7d0df2c57236dd49b612a0f8748
https://research.utwente.nl/en/publications/9f28e825-1d55-45d3-84a1-b7757ad5ece3
https://research.utwente.nl/en/publications/9f28e825-1d55-45d3-84a1-b7757ad5ece3
Autor:
Marian B. E. Menke-Pluijmers, Sabine Siesling, Sabine C. Linn, Lambertus A. Kiemeney, Gabe S. Sonke, Adri C. Voogd, A.B.G. Kwast
Publikováno v:
Breast Cancer Research and Treatment, 145, 2, pp. 503-11
Breast cancer research and treatment, 145(2), 503-511. Springer
Breast Cancer Research and Treatment, 145(2), 503-511. Springer, Cham
Breast Cancer Research and Treatment, 145, 503-11
Breast cancer research and treatment, 145(2), 503-511. Springer
Breast Cancer Research and Treatment, 145(2), 503-511. Springer, Cham
Breast Cancer Research and Treatment, 145, 503-11
Item does not contain fulltext Hormone receptor (HR) status is an important prognostic factor for patients with metastatic breast cancer (MBC) and is also correlated with other prognostic factors, such as initial lymph node status, HER2-Neu status an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67aca6c32741ce12e2300b0b710e47d7
https://hdl.handle.net/2066/136605
https://hdl.handle.net/2066/136605
Autor:
Isabelle Soerjomataram, Jan Willem Coebergh, Sabine Siesling, A.B.G. Kwast, Jan A. Roukema, L. Liu, Adri C. Voogd, Jan J. Jobsen
Publikováno v:
British journal of cancer, 107(3), 549-555. Nature Publishing Group
British Journal of Cancer, 107(3), 549-555. Nature Publishing Group
The British Journal of Cancer, 107, 549-555. Nature Publishing Group
British Journal of Cancer
British Journal of Cancer, 107(3), 549-555. Nature Publishing Group
The British Journal of Cancer, 107, 549-555. Nature Publishing Group
British Journal of Cancer
BACKGROUND: This study examined the risk of third cancer of non-breast origin (TNBC) among women with bilateral breast cancer (BBC; either synchronous or metachronous), focussing on the relation with breast cancer treatment. METHODS: Risk was assesse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e0c9f10d967b8e7195d5b9909c6a5dc
https://research.utwente.nl/en/publications/f3110c74-0fc0-4c83-ade5-dead400e764b
https://research.utwente.nl/en/publications/f3110c74-0fc0-4c83-ade5-dead400e764b